Dean Y. Li - Apr 1, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 07:21 PM
Previous filing
Feb 28, 2022
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1.54K +0.26% $0.00 599K Apr 1, 2022 Direct F1
holding RXRX Class A Common Stock 1.32M Apr 1, 2022 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.32M Apr 1, 2022 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.42M Apr 1, 2022 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 450K Apr 1, 2022 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.